İnal Ülgenalp

Unexpected Nature of a Pelvic Mass in Pregnancy: Castleman's Disease

The obstetrician is rarely confronted with a pregnant patient who presents with a large suspicious pelvic mass. Diagnostic tools are not always of value and laparotomy may be performed for obstetric and histopathologic reasons. In this article we present an interesting case of an unusual pelvic mass in pregnancy secondary to benign lymphoepithelial disease (Castlemans disease). We could not find a case similar to the one reported in the medical literature.

Primary squamous cell carcinoma of the endometrium

15@300 mg pamidronate daily tolerated treatment reasonably well but those receiving 450-600 mg daily had an unacceptable incidence of adverse events. The toxicities in patients receiving the effervescent tablet, at all dose levels, tended to be worse and in view of its inconvenient mode of administration, this formulation will not be studied further. 5 patients taking the effervescent formulation and 2 receiving the enteric-coated capsule stopped treatment because of poor tolerability. Studies of oral pamidronate as an adjunct to systemic therapy are now indicated. Toxicity was infrequent with the entericcoated capsule at a dose of 150-300 mg daily and is therefore suitable for further study. However, the search continues for an even better tolerated formulation.

Microsurgical transposition of the human fallopian tube.

Reports of tubal microsurgical transposition techniques to restore fertility are quite rare. In this article, an interesting microsurgical procedure, in a woman with congenital uterine and tubal abnormality is presented. Under certain circumstances, microsurgical transposition of the human fallopian tube has the potential of being a useful therapeutic alternative.